A detailed history of Washington Trust Advisors, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 115,660 shares of EW stock, worth $7.84 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
115,660
Previous 92,171 25.48%
Holding current value
$7.84 Million
Previous $8.51 Million 10.35%
% of portfolio
0.68%
Previous 0.8%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$59.7 - $93.78 $1.4 Million - $2.2 Million
23,489 Added 25.48%
115,660 $7.63 Million
Q2 2024

Jul 25, 2024

SELL
$84.3 - $94.31 $218,842 - $244,828
-2,596 Reduced 2.74%
92,171 $8.51 Million
Q1 2024

May 07, 2024

SELL
$72.54 - $95.56 $157,774 - $207,843
-2,175 Reduced 2.24%
94,767 $9.06 Million
Q4 2023

Jan 18, 2024

BUY
$61.71 - $77.76 $1.49 Million - $1.88 Million
24,142 Added 33.16%
96,942 $7.39 Million
Q3 2023

Oct 18, 2023

BUY
$69.28 - $93.38 $5,958 - $8,030
86 Added 0.12%
72,800 $5.04 Million
Q2 2023

Jul 27, 2023

SELL
$81.41 - $94.33 $814 - $943
-10 Reduced 0.01%
72,714 $6.86 Million
Q1 2023

May 04, 2023

SELL
$74.26 - $84.51 $23,614 - $26,874
-318 Reduced 0.44%
72,724 $6.02 Million
Q4 2022

Feb 08, 2023

BUY
$68.3 - $87.44 $440,535 - $563,988
6,450 Added 9.69%
73,042 $5.45 Million
Q3 2022

Oct 14, 2022

SELL
$82.37 - $107.29 $213,008 - $277,451
-2,586 Reduced 3.74%
66,592 $5.5 Million
Q2 2022

Jul 25, 2022

SELL
$86.5 - $128.27 $358,456 - $531,550
-4,144 Reduced 5.65%
69,178 $6.58 Million
Q1 2022

May 05, 2022

SELL
$101.96 - $128.34 $86,462 - $108,832
-848 Reduced 1.14%
73,322 $8.63 Million
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $7.89 Million - $9.69 Million
74,170 New
74,170 $9.61 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.